<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03006770</url>
  </required_header>
  <id_info>
    <org_study_id>PLX-CLI-03</org_study_id>
    <nct_id>NCT03006770</nct_id>
  </id_info>
  <brief_title>Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization</brief_title>
  <official_title>Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pluristem Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pluristem Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a randomized, placebo-controlled, parallel group, multicenter, Phase III
      study.The study aims to evaluate the Efficacy, Tolerability and Safety of Intramuscular
      Injections of PLX PAD for the Treatment of Subjects with Critical Limb Ischemia (CLI) with
      Minor Tissue Loss (Rutherford Category 5) who are Unsuitable for Revascularization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2017</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to major amputation or death (AFS)</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of any of the events (in index leg)-major amputation,revascularization due to worsening of CLI,doubling of total wound area from baseline,anew gangrene. All-cause mortality.</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to major amputation of the index leg.</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete wound healing in the index leg</measure>
    <time_frame>12 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemic pain (NRS).</measure>
    <time_frame>6 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to adjudicated major amputation of the index leg or death</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>Critical Limb Ischemia (CLI)</condition>
  <arm_group>
    <arm_group_label>PLX-PAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PLX-PAD will be administered via 30 IM injections (0.5 mL each). Each subject will be treated twice, with an interval of 8 weeks between treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be administered via 30 IM injections (0.5 mL each). Each subject will be treated twice, with an interval of 8 weeks between treatments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PLX-PAD</intervention_name>
    <description>Local intramuscular (IM) injections of PLX-PAD in the index leg.</description>
    <arm_group_label>PLX-PAD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Local intramuscular (IM) injections of Placebo in the index leg.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult male or female subjects between ages 45-99 years of age.

          2. CLI, with minor tissue loss up to the ankle level (Rutherford Category 5)

          3. Ankle pressure (AP) ≤70 mmHg or TP ≤50 mmHg in the index leg. (If a subject has ABI
             &gt;1.4 and TP is not measureable, inclusion may be based on TcPO2 ≤30 mmHg)

          4. Subject unsuitable for revascularization (by any method) in the index leg.

          5. Ischemic lesions in the index leg stable for at least 2 weeks.

          6. Ischemic ulcers in the index leg without tendon or bone exposure (unless secondary to
             a minor amputation).

          7. Under treatment for cardiovascular risk factors: hypertension, hyperlipidemia,
             diabetes, in accordance with applicable guidelines. Concomitant therapy with a statin
             and an anti-platelet agent for at least 2 weeks prior to randomization.

          8. Women of childbearing potential must have a negative serum pregnancy test at screening
             and must be willing to use at least one highly effective birth control method
             throughout the study.

          9. Signed informed consent form.

        Exclusion Criteria:

          1. Non-atherosclerotic PAD (e.g. Buerger's disease).

          2. CLI with major tissue loss (Rutherford Category 6) in either leg.

          3. Evidence of active infection (e.g., cellulitis, osteomyelitis).

          4. Subject having undergone surgical revascularization or major amputation less than 1
             month prior to screening, or endovascular revascularization or minor amputation less
             than 2 weeks prior to screening.

          5. Planned or potential need for major/minor amputation or any revascularization within 1
             month of study entry upon investigator's judgment.

          6. Aorto-iliac stenosis or common femoral artery stenosis ≥70%, or otherwise suspicion of
             inadequate inflow to the leg.

          7. Life expectancy of less than 6 months.

          8. Stroke or acute myocardial infarction/unstable angina within 3 months prior to
             screening.

          9. Severe congestive heart failure symptoms (New York Heart Association [NYHA] Stage IV).

         10. Uncontrolled severe hypertension.

         11. Diabetes mellitus with HbA1c &gt;10%.

         12. Current or history of proliferative retinopathy.

         13. Known Hepatitis B virus or Hepatitis C virus or acquired immunodeficiency syndrome
             (AIDS) infections.

         14. Subjects with international normalized ratio (INR) &gt;2.5.

         15. Subject on renal replacement therapy or with eGFR &lt;15 mL/min/1.73m2.

         16. Subject is currently enrolled in, or has not yet completed a period of at least 30
             days since ending another investigational device or drug trial(s), unless in long-term
             follow-up phase.

         17. Use of hyperbaric oxygen therapy, prostanoids, spinal cord stimulation, lumbar
             sympathectomy, wound dressing containing cells or growth factors, or topical platelet
             derived growth factor.

         18. Known allergies to any of the following: DMSO, human serum albumin, bovine serum
             albumin.

         19. History of allergic/hypersensitivity reaction to any substance having required
             hospitalization and/or treatment with IV steroids/epinephrine.

         20. Pulmonary disease requiring supplemental oxygen treatment on a daily basis.

         21. Active malignancy or history of malignancy within 5 years prior to study entry.

         22. In the opinion of the investigator, the subject is unsuitable for participating in the
             study.

         23. Inability to understand and provide an informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCI Medical Center 101 The City Drive S. Bldg 55 Rm 334 Orange, CA 92868</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Nguyen</last_name>
      <phone>714-456-5431</phone>
      <email>julin16@uci.edu</email>
    </contact>
    <contact_backup>
      <last_name>Trisha Maris</last_name>
      <email>thufnage@uci.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Isabella Kuo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center,LA,Beverly Hills,8536 Wilshire Boulevard, Third Floor</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suhail Dohad, Dr</last_name>
      <phone>310-248-8245</phone>
      <email>suhail.dohad@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Suhail Dohad, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Center ∣ Department of Surgery ∣ UC Davis Health 4860 Y street, Sacramento, CA suite #3400, 95817</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura B. Jones</last_name>
      <phone>916-734-4156</phone>
      <email>lbjjones@ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nataly Lessa Magner</last_name>
      <email>nlmagner@ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nasim Hedayati, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Center,Department of Surgery,UC Davis Health,4860 Y street</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura b Jones, Mrs.</last_name>
      <phone>530-302-5517</phone>
      <email>lbjjones@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Nasim Hedayati, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Leonard M.Miller School of Medicine (UMMSM)-UHealth Pulmonary and Critical Care Medicine-Rosenstiel Building Location</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136-1015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arash Bornak, MD</last_name>
      <phone>305-284-4093</phone>
      <email>abornak@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Arash Bornak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center (TMC) (Tufts-New England Medical Center)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111-1552</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Iafrati, MD</last_name>
      <phone>617-636-5019</phone>
      <email>miafrati@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Mark Iafrati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Room S3-746, Dept of Surgery, UMASS Medical School, 55 Lake Ave North.</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andres S Schanzer, Dr.</last_name>
      <phone>508-856-5599</phone>
      <phone_ext>5088565599</phone_ext>
      <email>Andres.schanzer@umassmemorial.org</email>
    </contact>
    <investigator>
      <last_name>Andres Schanzer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Rundback, Dr.</last_name>
      <phone>201-530-7967</phone>
      <email>jrundback@aivsllp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai St. Luke's hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019-1147</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John C Lantis, Dr.</last_name>
      <phone>212-523-5915</phone>
      <email>jlantis@chpnet.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center,Durham,2424 Erwin Road Hock Plaza</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Andrews</last_name>
      <phone>919-681-4624</phone>
      <email>jennifer.andrews@duke.edu</email>
    </contact>
    <investigator>
      <last_name>William Schuyler Jones, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Heart Clinical Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Gammon, MD</last_name>
      <phone>512-206-3600</phone>
      <email>roger.gammon@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Roger Gammon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Plastic Surgery ,Ut Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence Lavery, Dr.</last_name>
      <phone>214-786-5401</phone>
      <email>larry.lavery@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Virgin Mary&quot; EOOD,Clinic of Vascular Surgery</name>
      <address>
        <city>Burgas</city>
        <zip>8127</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galin Zhelev, Dr.</last_name>
      <phone>+359 89 62 62</phone>
      <email>gmzhelevm.d@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT Sveti Nokolay Chudotvorets EOOD - Lom,Surgery Department,Address 2, Todor Kableshkov str.</name>
      <address>
        <city>Lom</city>
        <zip>3600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iliyan Petrov, Dr.</last_name>
      <phone>+359 888 673 338</phone>
      <email>iliyan_petrov@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Iliyan Petrov, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;St. Georgi&quot; EAD,Clinic: Vascular Surgery and Angiology 66 &quot;Peshtersko Shosse&quot; Blvd., 8th floor, Hirurgicheski blok</name>
      <address>
        <city>Plovdiv</city>
        <zip>4001</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Drago Zhelev, Assoc. Prof.</last_name>
      <phone>+359 888 221 320</phone>
      <email>ddragozhelev@abv.bg</email>
    </contact>
    <investigator>
      <last_name>Drago Zhelev, Assoc. Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMBAL Kanev AD - Ruse,Department of Vascular Surgery Address: 2, Nezavisimost str</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgi Georgiev, Dr.</last_name>
      <phone>+359 888 244 262</phone>
      <email>dr.georgi.georgiev@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Georgi Georgiev, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Medica&quot; Ruse Department of Vascular Surgery 35, &quot;Riga&quot;, Str Post code: 7013 Ruse, Bulgaria</name>
      <address>
        <city>Ruse</city>
        <zip>7013</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamen Uzunov, Dr.</last_name>
      <phone>00359 886 23 74 81</phone>
      <email>kamenuzunov@abv.bg</email>
    </contact>
    <contact_backup>
      <last_name>Krasimira Yordanova, Dr.</last_name>
      <phone>00359 885 20 73 80</phone>
      <email>kraskoto_rs@abv.bg</email>
    </contact_backup>
    <investigator>
      <last_name>Hristo Georgiev, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MHAT National Heart Hospital EAD,Clinic of Vascular Surgery and angiology</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Stankev, Prof.</last_name>
      <phone>+359 2 822 31 36</phone>
      <email>mstanbg@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Acibadem City Clinic MHAT Tokuda, Vascular Surgery and Angiology 51B &quot;Nikola Vaptzarov&quot; Blvd</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasil Chervenkov, Prof.</last_name>
      <phone>+359 888 337 330</phone>
      <email>vassilchervenkoff170@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Vasil Chervenkov, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;St. Ekaterina&quot; EAD, Departement of Vascular Surgery</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentin Govedarski, Assoc. Prof.</last_name>
      <phone>+359 888 242 418</phone>
      <email>dvsg66@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cevni ambulance</name>
      <address>
        <city>Hodonín</city>
        <zip>69501</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matuska Jiri</last_name>
      <phone>00420518341182</phone>
      <email>jiri.matuska@matmed.cz</email>
    </contact>
    <investigator>
      <last_name>Matuska Jiri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Angiologicka ambulance</name>
      <address>
        <city>Ostrava Dubina</city>
        <zip>700 30</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dusan Kucera, MD</last_name>
      <phone>00420 595633202</phone>
      <email>dusan.kucera@vtn.agel.cz</email>
    </contact>
    <investigator>
      <last_name>Dusan Kucera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vseobecna Fakultni Nemocnice v Praze</name>
      <address>
        <city>Prague</city>
        <zip>12802</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Claude Lubanda, MD</last_name>
      <phone>00420 774988566</phone>
      <email>jean-claude.lubanda@vfn.cz</email>
    </contact>
    <investigator>
      <last_name>Jean-Claude Lubanda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intitute of Clinical and Experimental Medicine</name>
      <address>
        <city>Praha 4</city>
        <zip>140 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaroslav Chlupac, MD</last_name>
      <phone>00420 737385657</phone>
      <email>jaroslav.chlupac@ikem.cz</email>
    </contact>
    <investigator>
      <last_name>Jaroslav Chlupac, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krajska zdravotni a.s., Masarykova nemocnice o.z.</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>40113</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Sauer, MD</last_name>
      <phone>420 47 711 2504</phone>
      <email>martin.sauer@kzcr.eu</email>
    </contact>
    <contact_backup>
      <last_name>Olga Mucicova, Mgr</last_name>
      <phone>420 477 112 100</phone>
      <email>olga.mucicova@kzcr.eu</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Sauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Angiologie Universitätsklinikum Leipzig AöR Liebigstr. 20 04103 Leipzig, Germany</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janin Lenzer</last_name>
      <phone>0049-341-97 18774</phone>
      <email>Janin.Lenzer@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Andrej Schmidt, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medinos Klinikum Sonneberg Abteilung für Kardiologie/Angiologie - Studienambulanz Neustadter Straße 61 96515 Sonneberg Germany</name>
      <address>
        <city>Sonneberg</city>
        <state>Thueringen</state>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Hofrichter</last_name>
      <phone>00493675 821 754</phone>
      <email>Jennifer.Hofrichter@regiomed-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Marcus Thieme, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitats-Herzzentrum Freiburg</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Zeller, MD</last_name>
      <phone>0049 76334022431</phone>
      <email>thomas.zeller@herzzentrum.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Zeller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite Centrum fur Herz - Kreislauf - und Gefassmedizin - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Rauch, Dr.</last_name>
      <phone>030 450 513 794</phone>
      <email>ursula.rauch@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Franziska Bleis</last_name>
      <phone>49(0)30 450 513 817</phone>
      <email>Franziska.Bleis@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ursula Rauch, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Berlin-Buch, Klinik fur Angiologie</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Klein-Weigel, MD</last_name>
      <phone>30940154900</phone>
      <email>peter.klein-weigel@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Peter Klein-Weigel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Franziskus-Krankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Weiss, MD</last_name>
      <phone>+493514583659</phone>
      <email>Norbert.Weiss@uniklinikum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Norbert Weiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf (UKD)</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hubert Schelzig, Prof.</last_name>
      <phone>0049 2118107211 / 07219</phone>
      <email>gesund@med.uni-duesseldorf.de</email>
    </contact>
    <contact_backup>
      <last_name>Britta Londong</last_name>
      <phone>0049 211 81-07211</phone>
      <email>Britta.Londong@med.uni-duesseldorf.de</email>
    </contact_backup>
    <investigator>
      <last_name>Hubert Schelzig, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St.Georg-Angiologische Ambulanz</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sigrid Nikol, Prof.</last_name>
      <phone>401818852401</phone>
      <email>s.nikol@asklepios.com</email>
    </contact>
    <investigator>
      <last_name>Sigrid Nikol, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik Kösching Krankenhausstr. 19, 85092 Kösching Germany</name>
      <address>
        <city>Kösching</city>
        <zip>85092</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Hansen, Prof.</last_name>
      <phone>&quot;Telefon (08456) 71-431</phone>
      <email>Alexander.Hansen@klinikallianz.com</email>
    </contact>
    <investigator>
      <last_name>Alexander Hansen, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48155</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Reinecke, MD</last_name>
      <phone>0049 (0) 251 8346068</phone>
      <email>Holger.Reinecke@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Holger Reinecke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz</name>
      <address>
        <city>Szekesfehervar</city>
        <state>Fejer</state>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Menesi</last_name>
      <phone>0036209831112</phone>
      <email>vazoaktiv@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rudolf Menesi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szent Imre Egyetemi Oktato Korhaz</name>
      <address>
        <city>Budapest</city>
        <zip>1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katalin Farkas</last_name>
      <phone>0036 304648600</phone>
      <email>angiologia@szentimrekorhaz.hu</email>
    </contact>
    <investigator>
      <last_name>Katalin Farkas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flor Ferenc County Hospital</name>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zsolt Pecsvarady, MD</last_name>
      <phone>0036 209458919</phone>
      <email>zspecs@upcmail.hu</email>
    </contact>
    <investigator>
      <last_name>Zsolt Pecsvarady, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>B-A-Z County and University Teaching Hospital</name>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lajos Matyas, MD</last_name>
      <phone>0036 646323694</phone>
      <email>multifeet@chello.hu</email>
    </contact>
    <investigator>
      <last_name>Lajos Matyas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Josa Andras Megyei Korhaz</name>
      <address>
        <city>Nyíregyháza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geza Szabo</last_name>
      <phone>0036 42599700</phone>
      <email>dr.szabo.geza@vazomed.eu</email>
    </contact>
    <investigator>
      <last_name>Geza Szabo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem (PTE) Altalanos Orvostudomanyi Kar (AOK) (University of Pecs Medical School)</name>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Menyhei</last_name>
      <phone>0036 72 536 000</phone>
      <email>menyhei.gabor@pte.hu</email>
    </contact>
    <investigator>
      <last_name>Gabor Menyhei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery Department, Hadassah Ein Karem MC</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asaf Rabin, Dr.</last_name>
      <phone>972-2-6775231</phone>
      <email>ASAFR@HADASSAH.ORG.IL</email>
    </contact>
    <investigator>
      <last_name>Asaf Rabin, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery Department Rabin Medical Center Beilinson Hospital, 39 Jabotinski St. Petah Tikva Israel 4941492</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4941492</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Igor Manevych, Dr.</last_name>
      <phone>00972-54-4902547</phone>
      <email>igorm@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Galit Sivak, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cardiological Department, The Baruch Padeh Medical Center</name>
      <address>
        <city>Poriya</city>
        <zip>15208</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diab Ghanem, Dr.</last_name>
      <phone>04-6652363</phone>
      <email>dganem@poria.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Diab Ghanem, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem Sistina Hospital,Thoracic and Vascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitko Karagjozov, Prof.</last_name>
      <phone>+389 2 3099 720</phone>
      <email>mitko.karagjozov@acibademsistina.mk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Re-Medika General Hospital,Cardiovascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vlatko Cvetanovski, Dr.</last_name>
      <phone>+389 2 2603 100</phone>
      <email>vcvetanovski@remedika.com.mk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Special Hospital for Surgical Diseases Zan Mitrev Clinic ,Cardiovascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikola Hristov, Dr.</last_name>
      <phone>+389 (0)2 3091 500</phone>
      <email>nikola.hristov@zmc.mk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 1 im. dr. A. Jurasza</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85094</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Cathedra and Clinic of Vascular Surgery and Angiology-Klinika Chirurgii Naczyniowej i Angiologii</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Zubilewicz, Prof.</last_name>
      <phone>0048 815325707</phone>
      <email>tomzubil@poczta.onet.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 2 Pomorskiego Uniwersytetu Medycznego w Szczecinie</name>
      <address>
        <city>Szczecin</city>
        <zip>2359</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Specjalistyczny we Wroclawiu, Osrodek Badawczo-Rozwojowy,Intensywnego Nadzoru Kardlologleznego,</name>
      <address>
        <city>Wrocław</city>
        <zip>51-124</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wojciech Witkiewicz, Prof</last_name>
      <phone>0048 601703011</phone>
      <email>witkiewicz@wssk.wroc.pl</email>
    </contact>
    <investigator>
      <last_name>Wojciech Witkiewicz, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Research Clinical Research Centre Beaufort Way Southmead Hospital Westbury on Trym Bristol</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hinchliffe, Dr.</last_name>
      <phone>0044 2087253214</phone>
      <email>Robert.Hinchliffe@nbt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Robert Hinchliffe, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hull And East Yorkshire Women And Children's Hospital-Hull And East Yorkshire Hospitals Nhs Trust</name>
      <address>
        <city>Hull</city>
        <zip>HU32JZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Edward Smith, MD</last_name>
      <phone>00441482675784</phone>
      <email>georgeedsmith@gmail.com</email>
    </contact>
    <investigator>
      <last_name>George Edward Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Manu, MD</last_name>
      <phone>0203 299 3704</phone>
      <email>chris.manu@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Chris Manu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Vascular Research, St George's Hospital</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Loftus, Prof.</last_name>
      <phone>0044 2086721255</phone>
      <email>ian.loftus@stgeorges.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>North Macedonia</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Macedonia, The Former Yugoslav Republic of</country>
  </removed_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>December 27, 2016</study_first_submitted>
  <study_first_submitted_qc>December 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2016</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

